NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Tuesday that its third quarter revenues fell 2 percent year over year.

For the three months ended Sept. 30, the firm reported total revenues of $745,144, down from $759,663 in Q3 2016. Product sales fell to $729,742 from $730,325 in the year-ago quarter, while lab services revenues fell to $9,070 from $23,036, and collaboration revenues remained flat at $6,302.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.